• linkedin
  • Increase Font
  • Sharebar

    What’s going to be hot in 2018?

    What’s going to be hot in 2018?

    By Lisette Hilton

    What exciting new devices, drugs and treatments will the New Year bring dermatologists and their patients? Physicians in the specialty and others share what they most anticipate in the coming year.

    Enter the new neuromodulator?

    Dermatologist Rhonda Klein, M.D., M.P.H., says she is excited about continued research and potentially an FDA approval for the new neurotoxin Revance, (daxibotulinumtoxinA, RT002, Revance Therapeutics).

    Dr. Klein“Revance is an experimental long-lasting botulinum toxin that has shown efficacy for lasting 24-weeks or longer to the glabellar area in clinical trials. This is an exciting prospective offering for our patients that are needle averse, very busy, and want their wrinkles reduced for longer periods of time,” says Dr. Klein, who practices with Connecticut Dermatology Group and has no financial or research ties to Revance. “While we expect this product to be priced higher than Botox, Dysport or Xeomin, given the longer duration, many patients may opt for the convenience of less injections. We are excited to see how this plays out in practice, and how it compares to the other toxins that we are using regularly.”

    In December 2017, Revance Therapeutics announced RT002 was shown in two phase 3 trials to be safe and well-tolerated through 36 weeks.

    Study investigator Richard Glogau, M.D., clinical professor of dermatology, University of California, San Francisco  told Dermatology Times that the data show patients may only need treatment with RT002 twice a year, compared with every three or four months for currently available neuromodulators.

    Still, dermatologists could have to wait beyond 2018 for approval. Revance might not be commercially available until 2020, according to the company.

    Conflicts of interest for Dr. Klein: none.

    NEXT: Help for hyperhidrosis


    Lisette Hilton
    Lisette Hilton, president of Words Come Alive, has written about health care, the science and business of medicine, fitness and wellness ...


    You must be signed in to leave a comment. Registering is fast and free!

    All comments must follow the ModernMedicine Network community rules and terms of use, and will be moderated. ModernMedicine reserves the right to use the comments we receive, in whole or in part,in any medium. See also the Terms of Use, Privacy Policy and Community FAQ.

    • No comments available

    Latest Tweets Follow